Upendra
58 posts



Development of an HIV reporter virus that identifies latently infected CD4+ T cells biorxiv.org/cgi/content/sh… #bioRxiv





Research, led by @PrecVaccines scientists at @BostonChildrens was published today in @ScienceTM describing a protein-based #vaccine, paired with custom #adjuvants that showed efficacy potentially equivalent to that of current #mRNA vaccines. ow.ly/osRg50GP1BW








1) We just got a new preprint out where we tested different version of the spike for immunogenicity and protection in the mouse model. It turns our, in addition to having the two stabilizing prolines, deleting the polybasic cleavage site is very helpful. biorxiv.org/content/10.110…




#JNJInnovation & @BARDA select first cohort of @JLABS companies with the aim to combat #COVID19 as part of the #BLUEKNIGHT collaboration: jnjinnovation.com/node/blog-post…


1/ There are various tweets misinterpreting COVID-19 “pre-existing immunity” and making dangerous claims about herd immunity. Since many of those claims refer to our scientific papers, we will reiterate the facts. @SetteLab @ljiresearch @ScienceMagazine @CellCellPress

